此显著利润增长主要源于：本集团对策略性增效措施的专注落实，具体体现在行政及研究与开发(研发) 支出的优化;及其他收益增加，此增长主要来自截至2025年6月30日止6个月取得的汇兑收益。 智通财经APP讯，奥星生命科技(06118)发布公告，预期将取得截至2025年6月30日止6个月本公司拥有人 应占溢利约人民币2300万元至2500万元，而截至2024年6月30日止6个月本公司拥有人应占溢利约为人民 币588万元。 ...

奥星生命科技(06118)发布公告，预期将取得截至2025年6月30日止6个月本公司拥有人应占溢利约人民 币2300万元至2500万元，而截至2024年6月30日止6个月本公司拥有人应占溢利约为人民币588万元。 此显著利润增长主要源于：本集团对策略性增效措施的专注落实，具体体现在行政及研究与开发(研发) 支出的优化;及其他收益增加，此增长主要来自截至2025年6月30日止6个月取得的汇兑收益。 ...

要实现"十四五"圆满收官，做好下半年经济工作至关重要。 中共中央政治局7月30日召开会议，分析研究当前经济形势，部署下半年经济工作。会议继续将稳就 业、稳企业、稳市场、稳预期作为着力点，强调"保持政策连续性稳定性，增强灵活性预见性""努力完 成全年经济社会发展目标任务"，并作出一系列重要部署，释放了多重信号。 中国财政学会绩效专委会副主任委员张依群说，财政政策会继续保持更加积极状态，从加速、加力两个 方面推动经济增长、民生保障、"四稳"落实。 今年以来，积极财政政策靠前发力。新增地方政府债券额度4月底已全部下达地方。截至6月底，2025年 超长期特别国债资金预算已下达6583亿元。 张依群分析，下半年加速重点在加快新增政府债券发行和政策性金融工具使用，加大投资增量的实物转 化，持续巩固当前经济企稳良好态势，保证经济增长的稳定性和连续性；加力主要表现在提高财政资金 使用效益，坚决兜牢基层"三保"底线，加大化解隐性债务力度，维护社会和谐稳定。 宏观政策要持续发力、适时加力 宏观政策是经济保持平稳运行的重要推动力。会议强调，宏观政策要持续发力、适时加力。要落实落细 更加积极的财政政策和适度宽松的货币政策，充分释放政 ...

Core Viewpoint - The article emphasizes the importance of identifying investment opportunities with high safety margins and verifiable win rates in niche areas that align with national strategies and independent innovation [2]. Group 1: Investment Highlights - He Yuan Bio became the first company to pass the fifth set of listing standards on the Sci-Tech Innovation Board after a 700-day hiatus, allowing unprofitable companies with core technologies to go public [3]. - The investment firm Xinxin Capital has successfully backed multiple companies that have gone public, including Zhixiang Jintai, Ruichuang Weina, and Maiwei Bio, showcasing a high success rate in a challenging VC environment [4]. - Xinxin Capital manages approximately 5 billion yuan, with the total market value of its invested companies exceeding 300 billion yuan [5]. Group 2: Investment Strategy - Xinxin Capital's investment philosophy prioritizes "win rate over odds," focusing on high-barrier technologies and entrepreneurial spirit to enhance safety margins [10]. - The firm has made significant investments in key chip sectors, including CPU, GPU, and TPU, reflecting its strategy of investing in high-potential technology areas [10][11][13][14]. Group 3: Case Studies - He Yuan Bio's innovative "rice blood-making" technology has shown promising clinical results, leading to Xinxin Capital's investment during a critical phase of its development [7][8]. - The investment in Zhaoxin, a domestic CPU leader, was driven by its compatibility with the X86 ecosystem and lower risk of sanctions, aligning with Xinxin's focus on safety [12]. - Xinxin Capital's investment in Glanfi, a domestic GPU company, highlights its strategy of supporting firms with stable management and a focus on graphics rendering rather than high-risk AI GPU markets [13]. Group 4: Investment Principles - Xinxin Capital adheres to strict investment criteria, avoiding sectors outside of intelligent technology and life sciences, and focusing on companies with technological barriers and commercial viability [20]. - The "Xinxin Curve" illustrates the relationship between the development stages of hard tech companies and investment returns, guiding the timing of investments [21][24].

Core Viewpoint - The article discusses the achievements and strategies of the Hong Kong Investment Management Company (港投公司) under the leadership of its first CEO, Chen Jiaqi, emphasizing the importance of "patient capital" in transforming scientific research into practical applications and fostering industrial clusters in Hong Kong [2][5][15]. Summary by Sections Company Overview - 港投公司 was established in October 2022 with a management scale of 62 billion HKD, receiving substantial funding from the Hong Kong government [5][6]. - Chen Jiaqi, with 13 years of experience at the Hong Kong Monetary Authority, leads the company, focusing on leveraging government support to drive investment [5][6]. Investment Strategy - The company has invested in over 100 firms, with 5-10 planning to go public in Hong Kong [5][16]. - Chen emphasizes a three-tier selection process for investments: focusing on the right sectors, quality teams, and enterprises that address market pain points [7][8]. Key Sectors - The primary investment areas include hard technology, life sciences, and renewable/green technology, aligning with national strategies and addressing Hong Kong's industrial weaknesses [8][15]. - The company aims to invest in both foundational technologies and their applications, such as AI in healthcare and manufacturing [8][9]. Collaboration and Partnerships - 港投公司 has announced partnerships with various venture capital firms to create funds and platforms that support global Chinese tech entrepreneurs [11][12]. - The company aims to attract international capital and talent to Hong Kong, enhancing its role as a "super connector" in the global market [12][13]. Financial Leverage and Impact - Chen highlights a significant leverage effect, stating that every 1 HKD of government funding can attract 4 HKD of market investment, which is crucial for driving long-term capital into the region [13][15]. - The company is focused on achieving both financial returns and social value, ensuring that investments lead to products that are accessible, applicable, and affordable for the public [10][15]. Future Directions - 港投公司 plans to deepen international cooperation, expand its capital and talent networks, and strengthen the innovation ecosystem in Hong Kong [15][16]. - The company faces the challenge of balancing financial returns with enhancing Hong Kong's long-term competitiveness and integration into national strategies [16].

Core Viewpoint - Hong Kong Investment Management Company (referred to as "HKIMC") aims to transition Hong Kong's economy from traditional finance and real estate to technology and innovation, leveraging its role as a "super connector" and "super value creator" to attract international long-term capital and promote investment in key sectors [1][2]. Group 1: Company Overview - HKIMC has invested in over 100 companies, with 5 to 10 planning to go public in Hong Kong [2]. - The company was established in October 2022, with a management scale of 62 billion HKD [2]. - The CEO, Chen Jiaqi, has a background in the Hong Kong Monetary Authority, where she served for 13 years [2]. Group 2: Investment Strategy - The investment philosophy focuses on selecting the right sectors, quality teams, and companies that address market, economic, or social pain points [3]. - Key investment areas include hard technology, life sciences, and renewable and green technology, aligning with national strategies [3]. - The company aims to invest in both foundational models and application layers in artificial intelligence, emphasizing the importance of technology implementation [3]. Group 3: Social Value and Financial Returns - HKIMC requires portfolio companies to achieve a balance between financial returns and social value, encapsulated in the principle of "usable, affordable, and effective" [4]. Group 4: Collaboration and Ecosystem Building - HKIMC has announced partnerships with several venture capital firms to create specialized funds and investment platforms, focusing on global Chinese tech entrepreneurs and accelerating research outcomes [6]. - The company has achieved a significant capital leverage effect, attracting 4 HKD of market long-term capital for every 1 HKD of government funding invested [6]. - The collaborative approach emphasizes mutual respect and win-win outcomes, which is crucial in the current complex international environment [7].

Group 1 - The article emphasizes the role of Hong Kong as a hub for "patient capital," which is flexible in investment duration and fosters long-term partnerships among investors [1][2] - Approximately 80 global patient capital institutions gathered in Hong Kong, managing a total asset scale of $20 trillion, representing over 50% of global GDP [1][2] - The Hong Kong government is actively promoting the connection between local tech enterprises and international patient capital, facilitating direct financing opportunities [1][3] Group 2 - Hong Kong is positioned as a "super connector" for mainland tech companies, providing diverse cross-border financing channels and connecting them with global markets and partners [2][3] - The Hong Kong Investment Management Company was established to manage the "Future Fund," with an initial management scale of HKD 62 billion, aiming to attract more tech enterprises and patient capital [3] - The company focuses on hard technology, life sciences, and renewable/green technology, with over 100 projects already invested, highlighting artificial intelligence and embodied intelligence as key growth areas [3][4] Group 3 - Hong Kong's capital market is adapting to accommodate more high-potential companies that may not yet be profitable, providing exit mechanisms and value-added platforms for patient capital [3][4] - The establishment of a robust startup ecosystem in Hong Kong, including the Hong Kong Science Park and Cyberport, offers funding matching and professional support for startups [4][5] - The article concludes that Hong Kong's comprehensive innovation ecosystem enables mainland tech companies to accelerate growth and expand internationally [5]